|
Ainhoa Lucía has more than 15 years of experience in research, and is currently an Assistant Professor at the Department of Microbiology at the University of Zaragoza.
She graduated in biochemistry in 2004, and did his doctoral thesis at the GGM group at the University of Zaragoza, looking for cryptic antibiotic resistance genes in mycobacteria. During this period, she developed skills in classical and molecular microbiology techniques, fluorescence and confocal microscopy, use of bioinformatics tools and ability to work in a BSL3 laboratory. Part of the work carried out was the generation of two transposon mutants, which have subsequently been used in the group to identify genes involved in resistance to different compounds, thus helping to elucidate their mode of action.
Ainhoa did a short postdoctoral stay at the Center for Infectious Diseases belonging to Queen Mary University (London) with the aim of developing new tools to facilitate the study of the transport of compounds through mycobacterial membranes.
Subsequently, she worked as a postdoctoral researcher for four years in the Department of Genetics at the University of Malaga studying the role of the T3SS of the phytopathogenic bacterium Pseudomonas syringae in the host-plant interaction, as well as epigenetic changes induced in different plants by bacterial infection. During this period she learned plant biotechnology techniques as well as the study of epigenetics.
With a scientific career focused on the study of pathogenic bacteria, Ainhoa has worked in very diverse fields and with different methodologies. She has developed a broad profile of knowledge and handling of techniques, as well as a high capacity for adaptation and learning.
In 2014 she joined the University of Zaragoza again, focusing her research in drug development for mycobacteria and other pathogens. She was investigating nanotechnology-based applications for treating tuberculosis and S. aureus infections within a European project of the VII Program Marco (NAREB). During its progress, several prototypes of nano encapsulated antibiotics were developed, and their activity in vitro and in vivo was demonstrated. These results turned into several publications within the consortium, and represent a great advance for the development of nanotechnology based antibiotic therapies.
She is currently the co-IP of the European project ERA4TB for the development of new therapies against tuberculosis, leading the in vitro studies together with Dr. Santiago Ramón-García. The ERA4TB is a collaborative consortium with more than 30 partners including universities, research institutions and private companies. Ainhoa has been in charge of the implementation of the HFS for PK-PD studies at UNIZAR, as well as the harmonisation of experimental and reporting procedures within the consortium.
In addition, Ainhoa is responsible of collaborative research in partnership with private companies.
As a relevant contribution at the teaching level, she has launched the node in Zaragoza of the MicroMundo project, which is a Service-Learning and citizen science project that involves two educational levels (high school and university) and is carried out in a coordinated manner in more than 30 Spanish universities. She also supervises master students and postdocs.
She collaborates in dissemination activities, having some dissemination articles in local press.
UN SEXENIO DE INVESTIGACIÓN, RECONOCIDO POR LA ACPUA EL 24 DE JUNIO DE 2019
Acreditación a Ayudante Doctor por la ANECA el 27 de Enero de 2020
Acreditación a Contratado Doctor por la ANECA el 27 de Enero de 2020
Acreditación a Profesor de Universidad Privada por la ANECA el 27 de Enero de 2020
Acreditación a Profesor titular de Univerisdad por la ANECA el 5 de Junio de 2025 |
Cargando...
